Average Co-Inventor Count = 3.91
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Cellectar, Inc. (12 from 12 patents)
2. Cellectar Biosciences, Inc. (8 from 10 patents)
20 patents:
1. 11467159 - Luminescent phospholipid analogs for the identification and isolation of circulating tumor cells
2. 11439709 - Phospholipid ether analogs as cancer-targeting drug vehicles
3. 10004818 - Ether and alkyl phospholipid compounds for treating cancer and imaging and detection of cancer
4. 9925269 - Phospholipid ether analogs as cancer-targeting drug vehicles
5. 9616140 - Fluorescent phospholipid ether compounds, compositions, and methods of use
6. 9579406 - Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof
7. 9550002 - Phospholipid analogs as diapeutic agents and methods thereof
8. 9480754 - Phospholipid ether analogs as cancer-targeting drug vehicles
9. 9345718 - Phospholipid ether analogs as cancer-targeting drug vehicles
10. 9339564 - Ether and alkyl phospholipid compounds for treating cancer and imaging and detection of cancer
11. 8877159 - Phospholipid analogs as diapeutic agents and methods thereof
12. 8877160 - Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof
13. 8871181 - Fluorescent phospholipid ether compounds, compositions, and methods of use
14. 8540968 - Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof
15. 8535641 - Phospholipid analogs as diapeutic* agents and methods thereof